ATE172201T1 - Morphinan-derivate und medizinische verwendung - Google Patents

Morphinan-derivate und medizinische verwendung

Info

Publication number
ATE172201T1
ATE172201T1 AT93902520T AT93902520T ATE172201T1 AT E172201 T1 ATE172201 T1 AT E172201T1 AT 93902520 T AT93902520 T AT 93902520T AT 93902520 T AT93902520 T AT 93902520T AT E172201 T1 ATE172201 T1 AT E172201T1
Authority
AT
Austria
Prior art keywords
medical uses
nch3
morphinane derivatives
morphinane
derivatives
Prior art date
Application number
AT93902520T
Other languages
English (en)
Inventor
Hiroshi Nagase
Koji Kawai
Kuniaki Kawamura
Jun Hayakawa
Takashi Endo
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Application granted granted Critical
Publication of ATE172201T1 publication Critical patent/ATE172201T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Fertilizers (AREA)
  • Saccharide Compounds (AREA)
AT93902520T 1992-01-23 1993-01-22 Morphinan-derivate und medizinische verwendung ATE172201T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1011592 1992-01-23
JP29430892 1992-11-02

Publications (1)

Publication Number Publication Date
ATE172201T1 true ATE172201T1 (de) 1998-10-15

Family

ID=26345314

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902520T ATE172201T1 (de) 1992-01-23 1993-01-22 Morphinan-derivate und medizinische verwendung

Country Status (15)

Country Link
US (2) US6323212B1 (de)
EP (2) EP0577847B1 (de)
JP (1) JP2525552B2 (de)
KR (1) KR970011390B1 (de)
AT (1) ATE172201T1 (de)
AU (2) AU666702B2 (de)
CA (1) CA2105072C (de)
DE (1) DE69321525T2 (de)
DK (1) DK0577847T3 (de)
ES (1) ES2121988T3 (de)
FI (1) FI106126B (de)
NO (1) NO302755B1 (de)
NZ (1) NZ246687A (de)
TW (1) TW332814B (de)
WO (1) WO1993015081A1 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2121988T3 (es) 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
CN1111900A (zh) * 1993-06-30 1995-11-15 东丽株式会社 止咳药
KR100341950B1 (ko) * 1993-07-19 2002-11-29 도레이 가부시끼가이샤 뇌세포보호제
NZ268969A (en) * 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
SE9401727D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds I
DE19602970A1 (de) * 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue 7,8- Dihydromorphinderivate, Verfahren zu deren Herstellung und deren Verwendung
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
EP0829481A1 (de) * 1996-09-16 1998-03-18 Pfizer Inc. Morphinan-Hydroxamsäure-Derivate
DE69732868T2 (de) * 1996-11-25 2006-04-13 Toray Industries, Inc. Mittel gegen Juckreiz
US6187782B1 (en) 1997-03-27 2001-02-13 Toray Industries, Inc. Morphinane derivatives and medicinal use thereof
PT948965E (pt) * 1997-07-11 2004-08-31 Toray Industries Composicoes medicinais estaveis contendo um derivado de 4,5-epoximorfinano
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
CA2288828A1 (en) * 1997-07-14 1999-01-28 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
WO1999005146A1 (en) * 1997-07-25 1999-02-04 Toray Industries, Inc. Hyponatremia remedies
JP4359711B2 (ja) * 1997-09-02 2009-11-04 東レ株式会社 薬物依存症治療薬
US6083944A (en) * 1997-10-07 2000-07-04 Cephalon, Inc. Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
TW570920B (en) * 1998-12-22 2004-01-11 Janssen Pharmaceutica Nv 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
CN1204139C (zh) * 1999-08-24 2005-06-01 东丽株式会社 神经性疼痛治疗剂
JP2003515375A (ja) * 1999-12-03 2003-05-07 イオウリ マロヴ， 拡散スペクトル技術による現場試験
WO2001074819A1 (en) * 2000-04-03 2001-10-11 Toray Industries, Inc. Analgesics containing morphinan n-oxide derivatives as the active ingredient
US8338442B2 (en) * 2001-03-30 2012-12-25 Toray Industries, Inc. Remedies for psychoneurosis
WO2002080918A1 (en) * 2001-04-02 2002-10-17 Toray Industries, Inc. Remedial or prophylactic agent for frequent urination or urinary incontinence
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
CA2486157C (en) 2002-05-17 2013-04-16 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
BR0314754A (pt) 2002-10-09 2005-07-26 Toray Industries Agente terapêutico ou profilático para a frequência urinária ou a incontinência urinária ou um seu sal de adição de ácido farmaceuticamente aceitável, método para terapia ou profilaxia para frequência urinária, urgência urinária ou incontinência urinária, uso de um derivado de morfina tendo um grupo heterocìclico contendo nitrogênio ou de um seu sal de adição de ácido farmaceuticamente aceitável, derivado de morfina ou um seu sal de adição de ácido farmaceuticamente aceitável, produto farmacêutico, e, composição farmacêutica
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP1628664A4 (de) * 2003-06-04 2008-11-05 Alkermes Inc Polymorphe formen von naltrexon
CA2568249C (en) * 2004-05-28 2014-12-09 Human Biomolecular Research Institute Synthesis of metabolically stable analgesics, pain medications and other agents
PE20060723A1 (es) * 2004-11-04 2006-08-29 Toray Industries Derivados de morfina como agentes analgesicos
WO2006109671A1 (ja) * 2005-04-06 2006-10-19 Toray Industries, Inc. モルヒナン誘導体の結晶及びその製造法
ES2307352B1 (es) * 2005-04-12 2009-09-18 Bti, I+D, S.L. Implante dental y piezas destinadas a ser conectadas a un implante dental, y la conexion interna entre el implante dental y cada pieza.
ES2629766T3 (es) 2006-04-21 2017-08-14 Nektar Therapeutics Reducción estereoselectiva de una morfinona
PL2151240T3 (pl) 2007-04-24 2014-01-31 Toray Industries Środek terapeutyczny lub profilaktyczny przeciw dyskinezie
PT2151241E (pt) 2007-04-26 2012-05-07 Toray Industries Preparação sólida estável compreendendo um derivado de 4,5-epoximorfinano
EP2168580B1 (de) 2007-06-22 2015-12-02 Toray Industries, Inc. Heilmittel oder prophylaktikum für schizophrenie
PL2196206T3 (pl) 2007-10-05 2020-02-28 Toray Industries, Inc. Środek do łagodzenia problemów skórnych zawierający pochodną morfinanu lub jego farmakologicznie dopuszczalną kwasową sól addycyjną jako substancję czynną
ES2671897T3 (es) * 2008-02-14 2018-06-11 Alkermes, Inc. Compuestos opioides selectivos
US8609682B2 (en) 2008-07-11 2013-12-17 Regents Of The University Of Minnesota Analgesic agents
CA2740476C (en) 2008-10-24 2016-04-05 Toray Industries, Inc. Stable tablet containing 4,5-epoxymorphinan derivative
CN102325776A (zh) * 2009-02-23 2012-01-18 马林克罗特公司 (+)-吗啡喃*季盐及其制备方法
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8563724B2 (en) * 2009-02-23 2013-10-22 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
EP2398806A1 (de) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-morphinanium-n-oxide und verfahren zu ihrer herstellung
US8471023B2 (en) * 2009-06-11 2013-06-25 Mallinckrodt Llc Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer
US8519133B2 (en) * 2009-06-11 2013-08-27 Mallinckrodt Llc Preparation of 6-alpha-amino N-substituted morphinans by catalytic hydrogen transfer
US10363251B2 (en) 2009-07-16 2019-07-30 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
PH12012501552A1 (en) 2010-01-29 2017-04-26 Toray Industries Therapeutic or prophylactic agent for biliary diseases
EP2580201B1 (de) 2010-06-11 2017-08-02 Rhodes Technologies Übergangsmetallkatalysierte verfahren zur herstellung von n-allyl-verbindungen und ihre verwendung
CA2802294C (en) 2010-06-11 2016-05-10 Rhodes Technologies Process for n-dealkylation of tertiary amines
AU2010357625B2 (en) * 2010-07-16 2015-04-23 Mallinckrodt Llc (+)-morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof
WO2012054566A2 (en) 2010-10-19 2012-04-26 Memorial Sloan-Kettering Cancer Center 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain
CA2825165C (en) 2011-01-31 2018-07-03 Toray Industries, Inc. Therapeutic or prophylactic agent for cachexia
KR20140036215A (ko) 2011-06-09 2014-03-25 말린크로트 엘엘씨 촉매 수소 전달에 의한 6-케토 모르피난의 환원 아미노화
MX2014002630A (es) 2011-09-08 2014-04-14 Mallinckrodt Llc Produccion de alcaloides sin el aislamiento de compuestos intermediarios.
WO2014028829A1 (en) 2012-08-16 2014-02-20 The Scripps Research Institute Novel kappa opioid ligands
TWI449704B (zh) * 2013-04-26 2014-08-21 Everlight Chem Ind Corp 嗎啡喃衍生物之結晶、其製造方法、及使用其之醫藥組成物
ES2784690T3 (es) 2013-12-05 2020-09-29 Univ Bath Nuevos compuestos opioides y sus usos
JP2015166331A (ja) * 2014-05-14 2015-09-24 遼東化学工業株式会社 ナルフラフィンの結晶およびその製造方法
WO2016152953A1 (ja) * 2015-03-24 2016-09-29 東レ株式会社 モルヒナン誘導体及びその医薬用途
EP4212532A3 (de) 2015-04-30 2023-09-27 Memorial Sloan Kettering Cancer Center Mitragynin-analoga und verwendungen davon
WO2017073710A1 (ja) 2015-10-29 2017-05-04 東レ株式会社 モルヒナン誘導体及びその医薬用途
US11529340B2 (en) 2016-03-22 2022-12-20 Regents Of The University Of Minnesota Combination for treating pain
US10988481B2 (en) * 2016-05-19 2021-04-27 Virginia Commonwealth University Potent and selective mu opioid receptor modulators
JP6814470B2 (ja) 2017-02-10 2021-01-20 国立大学法人 筑波大学 モルヒナン誘導体
JP2021515038A (ja) * 2018-02-27 2021-06-17 デルポー・インコーポレイテッドＤｅｌｐｏｒ， Ｉｎｃ． 小分子治療剤化合物のための組成物
DK3761982T3 (da) 2018-03-08 2025-01-02 Victoria Link Ltd Anvendelse af nalfurafin til behandling af demyeliniserende sygdomme
WO2020205735A1 (en) 2019-03-29 2020-10-08 Humanwell Pharmaceutical US Novel morphinans useful for treating medical disorders
EP3997092A4 (de) * 2019-07-08 2023-09-06 University of Health Sciences & Pharmacy in St. Louis G-protein-beeinflusster opioidrezeptoragonist/analgetika mit reduzierter arrestinrekrutierung
EP4039331A4 (de) 2019-09-30 2024-01-17 Nippon Chemiphar Co., Ltd. Azepinderivate
KR20220087427A (ko) 2019-10-24 2022-06-24 도레이 카부시키가이샤 악액질의 치료제 또는 예방제
TWI893157B (zh) * 2020-06-30 2025-08-11 日商東麗股份有限公司 具有嗎啡喃骨架之化合物或其藥理學上可容許之酸加成鹽的用途
CN115181109B (zh) * 2021-04-02 2024-06-04 南京正大天晴制药有限公司 吗啡喃衍生物的晶体及其制备方法
US20240197718A1 (en) 2021-04-23 2024-06-20 Toray Industries, Inc. Therapeutic or prophylactic agent for cachexia accompanied by ghrelin resistance
US20240300939A1 (en) 2021-06-14 2024-09-12 Scorpion Therapeutics, Inc. Urea derivatives which can be used to treat cancer
CN115960108B (zh) * 2021-10-09 2026-02-03 山东新时代药业有限公司 一种无定型盐酸纳呋拉啡及其制备方法
WO2023190665A1 (ja) * 2022-03-29 2023-10-05 東レ株式会社 モルヒナン誘導体及びその医薬用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236851A (en) * 1966-02-22 Unsaturated morphinan derivatives
NL290054A (de)
DE622231C (de) * 1934-03-09 1935-11-23 Hermann Fischer Dr Verfahren zur Herstellung von Diacetylmorphin
GB864107A (en) 1958-09-10 1961-03-29 Albert Boehringer Morphine derivatives
GB919311A (en) 1958-10-29 1963-02-20 T & H Smith Ltd Derivatives of 14-hydroxycodeine and their preparation
DE2254298A1 (de) * 1972-11-06 1974-05-16 Boehringer Sohn Ingelheim Neue (heteroarylmethyl)-normorphine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
GB1587831A (en) * 1977-03-23 1981-04-08 Reckitt & Colmann Prod Ltd Morphine derivatives
GB1593191A (en) * 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
US4362870A (en) 1980-01-16 1982-12-07 Regents Of The University Of Minnesota Selective opioid receptor alkylating agents
JPS574991A (en) 1980-06-10 1982-01-11 Sankyo Co Ltd Cyclopropylmethylnormorphine-6-sulfuric ester
US4401672A (en) 1981-10-13 1983-08-30 Regents Of The University Of Minnesota Non-addictive narcotic antitussive preparation
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US4767718A (en) * 1984-06-18 1988-08-30 Southern Illinois University Foundation Fluorescent opioid reagents and methods of use thereof in the detection of opioid receptors
IN163125B (de) 1985-01-08 1988-08-13 Alkaloida Vegyeszeti Gyar
HU196376B (en) 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
DE3617182A1 (de) 1985-05-23 1986-11-27 Sandoz-Patent-GmbH, 79539 Lörrach Morphinan-derivate
US4806556A (en) 1985-12-12 1989-02-21 Regents Of The University Of Minnesota Gut-selective opiates
US4730048A (en) 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
JPH01149788A (ja) 1987-12-08 1989-06-12 Chugai Pharmaceut Co Ltd 新規なモルヒネ誘導体
FR2636330B1 (fr) 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
EP0374919A1 (de) 1988-12-21 1990-06-27 Chugai Seiyaku Kabushiki Kaisha Morphinderivat
US5219861A (en) * 1988-12-21 1993-06-15 Chugai Seiyaku Kabushiki Kaisha 6 β-Thiomorphine derivatives
US5258386A (en) * 1991-06-05 1993-11-02 The United States Of America As Represented By The Secretary Of The Army (+)-3-substituted-N alkylmorphinans, synthesis and use as anticonvulsant and neuroprotective agents
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
CN1111900A (zh) * 1993-06-30 1995-11-15 东丽株式会社 止咳药

Also Published As

Publication number Publication date
WO1993015081A1 (en) 1993-08-05
US6323212B1 (en) 2001-11-27
FI106126B (fi) 2000-11-30
NZ246687A (en) 1996-12-20
AU4067195A (en) 1996-03-07
ES2121988T3 (es) 1998-12-16
CA2105072C (en) 1998-07-28
CA2105072A1 (en) 1993-07-24
FI934144L (fi) 1993-09-22
AU3367193A (en) 1993-09-01
EP0577847A4 (de) 1994-12-07
EP0577847A1 (de) 1994-01-12
NO933376L (no) 1993-09-23
NO933376D0 (no) 1993-09-22
US6277859B1 (en) 2001-08-21
JPH08502275A (ja) 1996-03-12
DE69321525D1 (de) 1998-11-19
JP2525552B2 (ja) 1996-08-21
EP0846694A1 (de) 1998-06-10
KR970011390B1 (ko) 1997-07-10
AU666702B2 (en) 1996-02-22
DK0577847T3 (da) 1999-06-23
EP0577847B1 (de) 1998-10-14
NO302755B1 (no) 1998-04-20
AU686483B2 (en) 1998-02-05
DE69321525T2 (de) 1999-03-04
TW332814B (en) 1998-06-01
FI934144A0 (fi) 1993-09-22

Similar Documents

Publication Publication Date Title
ATE172201T1 (de) Morphinan-derivate und medizinische verwendung
NO941101D0 (no) Quinazolin-derivater
KR960702464A (ko) Dc-89 유도체[dc-89 derivative]
ATE116306T1 (de) Hypoglykämische oxazolidindion-derivate.
ATE129498T1 (de) Kondensierte heterozyklische verbindungen, ihre herstellung und verwendung.
ATE247654T1 (de) Neue heterozyklische verbindungen
DE69428977D1 (de) Arzneimittel gegen Parkinsonsche Krankheit
FI943142A0 (fi) Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt
DE69505470D1 (de) Pyrrolocarbazol
YU46998B (sh) Postupak za dobijanje derivata cefema i medjuproizvoda za iste
NO944371L (no) Kjemisk forbindelse med blodplateaggregeringsinhibiotoraktivitet
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
DK147588A (da) Benzoxazinderivat samt fremgangsmaade til fremstilling deraf
FI906021A0 (fi) Oxetanderivat, framstaellning av dessa samt anvaendning som svampmotverkande eller foerstoerande aemnen.
ATE55057T1 (de) Zentralwirkende muskelrelaxante.
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
PT99250A (pt) Processo para a preparacao de derivados de piperazina
JPS56131571A (en) Novel hetero ring substituted carboxyamide and methyl amine compound
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.
IT1204960B (it) Composti dotati di attivita' antiallergica
IT1204959B (it) Composti dotati di attivita' antiallergica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification